Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

CYTKCYTK
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in CYTOKINETICS INC

GOLDMAN SACHS GROUP INC holds 1.8M shares of CYTK (CYTOKINETICS INC), worth $150.1M as of 2026-Q2. The position was decreased (-20.1% shares). CYTK represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$150.1M

Current Shares

1.8M

Total Value Change

+$93.4M

Total Shares Change

+556,157

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.8M
-20.1%
$150.1M0.0%$85.19
0
2026-Q1
Decreased
2.2M
-7.0%
$145.4M0.0%$65.91
0
2025-Q4
Increased
2.4M
+45.1%
$150.7M0.0%$63.54
41
2025-Q3
Increased
1.6M
+28.3%
$89.8M0.0%$54.96
37
2025-Q2
Decreased
1.3M
-6.5%
$42.1M0.0%$33.04
0
2025-Q1
Increased
1.4M
+13.1%
$54.8M0.0%$40.19
33
2024-Q4
New
1.2M
-
$56.7M0.0%$47.04
41

Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used